NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

BGLC

BioNexus Gene Lab Corp

Apr 04 • 12:21PM ET

0.2512

Dollar change -0.0363
Percentage change -12.61	%

Basic Materials • Specialty Chemicals • Malaysia • NASD

Peers: ILMN GH EXAS QGEN MYGN CRSP FATE FLGT CGEN EDIT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.05	Insider Own	38.60%	Shs Outstand	17.97M	Perf Week	0.46%
Market Cap	4.52M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	11.03M	Perf Month	-27.17%
Income	-0.94M	PEG	-	EPS next Q	-	Inst Own	0.99%	Short Float	2.12%	Perf Quarter	-37.03%
Sales	9.26M	P/S	0.49	EPS this Y	-	Inst Trans	36.12%	Short Ratio	0.32	Perf Half Y	-42.08%
Book/sh	0.52	P/B	0.48	EPS next Y	-	ROA	-8.38%	Short Interest	0.23M	Perf Year	-57.63%
Cash/sh	0.23	P/C	1.09	EPS next 5Y	-	ROE	-9.87%	52W Range	0.21 - 1.00	Perf YTD	-10.17%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-9.84%	52W High	-74.88%	Beta	1.63
Dividend TTM	-	Quick Ratio	3.99	Sales past 5Y	-	Gross Margin	12.66%	52W Low	19.36%	ATR (14)	0.04
Dividend Ex-Date	-	Current Ratio	4.98	EPS Y/Y TTM	72.49%	Oper. Margin	-24.71%	RSI (14)	38.68	Volatility	18.65% 11.12%
Employees	-	Debt/Eq	0.02	Sales Y/Y TTM	-10.42%	Profit Margin	-10.17%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	51.86%	Payout	-	Rel Volume	2.17	Prev Close	0.29
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	3.00%	Earnings	-	Avg Volume	728.05K	Price	0.25
SMA20	-16.68%	SMA50	-26.51%	SMA200	-33.72%	Trades		Volume	735,736	Change	-12.61%

Mar-08-25 11:10AM	Bionexus Gene Lab enters partnership with ML Tech (TipRanks)
Mar-07-25 11:00AM	BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy (GlobeNewswire) +6.96%
Mar-05-25 11:00AM	BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper (GlobeNewswire)
Sep-25-24 11:31AM	BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. (GlobeNewswire)
Sep-13-24 12:05PM	BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. (GlobeNewswire)
01:23PM	Loading…
Sep-12-24 01:23PM	BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions (GlobeNewswire) +8.36%
Sep-11-24 11:05AM	BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production (GlobeNewswire)
Aug-27-24 11:35AM	BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd (GlobeNewswire)
Aug-26-24 12:15PM	BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd (GlobeNewswire)
Jul-15-24 07:35AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday (InvestorPlace)
Apr-19-24 08:58AM	Why Is BioNexus Gene Lab (BGLC) Stock Down 27% Today? (InvestorPlace) -29.32%
Apr-18-24 02:52PM	BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare (GlobeNewswire) +34.00%
Jul-24-23 11:30AM	BioNexus Gene Lab Corp. Announces Closing of $5.75 Million Public Offering and Full Exercise of Over-Allotment Option and Uplisting to the Nasdaq Capital Market (GlobeNewswire) -10.08%
Jul-20-23 01:29PM	BioNexus Gene Lab Corp. Announces Pricing of $5 Million Public Offering and Uplisting to the Nasdaq Capital Market (GlobeNewswire) -55.40%

BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BGLC

BioNexus Gene Lab Corp

Upgrade your FINVIZ experience